What's new

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

Feb 20, 2025 - 14:30
 0
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2...

Next Article

New Look liquidates Irish business

Related Posts

EMEA-003174-PIP01-21-M01

EMEA-003174-PIP01-21-M01

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Veterinary medicines European public assessment report (EPAR): Icthiovac ERM, inactivated vaccine against yersiniosis , Status: Authorised

Veterinary medicines European public assessment report ...

Feb 24, 2025  0